Alpha Cognition Inc
ACOGHealthcare|Biotechnology|US
$8.29
+0.14 (+1.72%)
DCF Value
$6.49
Tangible Book / Share
$2.15
Cash / Share
$1.90
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07633470 A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) | Alzheimer Disease | P4 | Recruiting | 150 | Open-label | Zunveyl® |